Jornalwebdigital: Elicio Therapeutics

Mostrando postagens com marcador Elicio Therapeutics. Mostrar todas as postagens

Elicio Therapeutics Reports Robust T cell Responses Across Diverse HLA backgrounds in Ongoing Phase 2 AMPLIFY-7P Trial

ELI-002 7P demonstrated robust mKRAS-specific T cell responses across a broad range of HLA types, highlighting its potential for use among a...Leia Mais

Assinar: Comentários ( Atom )

Últimas

Elicio Therapeutics Reports Robust T cell Responses Across Diverse HLA backgrounds in Ongoing Phase 2 AMPLIFY-7P Trial

Facebook

Seguidores

+ Lidas

Recent Posts

Recent Comments

Educação

PRNewswire

Moda & Beleza

PRNewswireNews

Info & Ti

PRNewswireEsp